NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss...
Quartz mentions APC
In a piece on the battle between Eli Lilly and compounding pharmacists over tirzepatide — notably the lawsuit by the Outsourcing Facilities Association — Quartz magazine referenced APC’s statement telling 503A members to “immediately cease preparing and dispensing compounded copies of Mounjaro and Zepbound.”
